Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Incyte Corporation
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female subjects, age 18 years or older.
Presence of measurable disease that has been confirmed by histology or cytology.
Must not be a candidate for potentially curative therapy or standard-of-care approved therapy
Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2.
You may not be if
Receipt of anticancer medications, anticancer therapies, or investigational drugs within the defined interval before the first administration of study drug.
Any unresolved toxicity ≥ Grade 2 from previous anticancer therapy except for stable chronic toxicities (≤ Grade 2) not expected to resolve.
Laboratory and medical history parameters outside Protocol-defined range.
Known additional malignancy that is progressing or requires active treatment.
Clareo Health | An Open-Label, Dose-Escalation/Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced Malignancies
